Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v5-EN
Language English English
Date Updated 2019-01-23 2019-01-22
Drug Identification Number 02248151 02248151
Brand name ALPHAGAN P ALPHAGAN P
Common or Proper name brimonidine tartrate brimonidine tartrate
Company Name ALLERGAN INC ALLERGAN INC
Ingredients BRIMONIDINE TARTRATE BRIMONIDINE TARTRATE
Strength(s) 0.15% 0.15%
Dosage form(s) SOLUTION SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 10mL 10mL
ATC code S01EA S01EA
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2019-01-21 2019-01-21
Actual start date 2019-01-21 2019-01-21
Estimated end date 2019-01-28 2019-01-28
Actual end date 2019-01-22
Shortage status Resolved Actual shortage
Company comments Production delay on 10mL - Alphagan P 5mL still available Production delay on 10mL - Alphagan P 5mL still available
Health Canada comments